Clinical activity of bortezomib in relapsed/refractory MALT...

Annals of Oncology 2011 / 03 Vol. 22; Iss. 3

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)

Conconi, A., Martinelli, G., Lopez-Guillermo, A., Zinzani, P. L., Ferreri, A. J. M., Rigacci, L., Devizzi, L., Vitolo, U., Luminari, S., Cavalli, F., Zucca, E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdq416
Date:
March, 2011
File:
PDF, 177 KB
english, 2011
Conversion to is in progress
Conversion to is failed